Featured Product

Quill™ Knotless Tissue-Closure Device. Wound closure made possible by bidirectional fixation within the tissue.

  • Eliminates the need to tie knots
  • May increase operating efficiency
  • May help reduce tissue
    trauma, facilitate healing
    and minimize scarring

Learn more about the
Quill™ Knotless
Tissue-Closure Device ...

About Us

Biology for Surgeons. It's what we do.

We bring the power of biology and pharmaceutical sciences to the hands of the surgeon and interventionalist to make their procedures more effective and safer for the patient.

Learn more about Angiotech...

Investor Relations Information

For current Investor Information please visit our FAQ page, click here.

Breaking News

  • May 15 - Angiotech Announces Financial Results for the First Quarter ended March 31, 2012 Read More...
  • Apr 30 - Angiotech Pharmaceuticals Announces Conference Call and Webcast - First Quarter 2012 Financial Result Read More...
  • Apr 4 - Angiotech Pharmaceuticals, Inc. Announces Transaction with Johnson & Johnson Relating to Angiotech's Quill Technology Read More...